1978 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: A dose-finding study

Fabi, A., Mirri, A., Felici, A., Vidiri, A., Pace, A., Occhipinti, E., Cognetti, F., Arcangeli, G., Iandolo, B., Carosi, M. A., Metro, G. & Carapella, C. M., Mar 2008, In : Journal of Neuro-Oncology. 87, 1, p. 79-84 6 p.

Research output: Contribution to journalArticle

Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree

Gelibter, A., Malaguti, P., Di Cosimo, S., Bria, E., Ruggeri, E. M., Carlini, P., Carboni, F., Ettorre, G. M., Pellicciotta, M., Giannarelli, D., Terzoli, E., Cognetti, F. & Milella, M., Sep 15 2005, In : Cancer. 104, 6, p. 1237-1245 9 p.

Research output: Contribution to journalArticle

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: An open-label, 2 × 2 factorial, randomised phase 3 trial

Del Mastro, L., De Placido, S., Bruzzi, P., De Laurentiis, M., Boni, C., Cavazzini, G., Durando, A., Turletti, A., Nisticò, C., Valle, E., Garrone, O., Puglisi, F., Montemurro, F., Barni, S., Ardizzoni, A., Gamucci, T., Colantuoni, G., Giuliano, M., Gravina, A., Papaldo, P. & 4 others, Bighin, C., Bisagni, G., Forestieri, V. & Cognetti, F., May 9 2015, In : Lancet. 385, 9980, p. 1863-1872 10 p.

Research output: Contribution to journalArticle

Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?

Carlini, P., Frassoldati, A., Marco, S. D., Casali, A., Ruggeri, E. M., Nardi, M., Papaldo, P., Fabi, A., Paoloni, F. & Cognetti, F., 2001, In : Annals of Oncology. 12, 11, p. 1539-1543 5 p.

Research output: Contribution to journalArticle

Functional and pharmacodynamic evaluation of metronomic cyclophosphamide and docetaxel regimen in castration-resistant prostate cancer

Cardillo, I., Spugnini, E. P., Galluzzo, P., Contestabile, M., Dellanna, M. L., Picardo, M., Crispi, S., Calogero, R. A., Piccolo, M. T., Arigoni, M., Cantarella, D., Boccellino, M., Quagliuolo, L., Ferretti, G., Carlini, P., Felici, A., Boccardo, F., Cognetti, F. & Baldi, A., Sep 2013, In : Future Oncology. 9, 9, p. 1375-1388 14 p.

Research output: Contribution to journalArticle

Future directions in the second-line treatment of non-small cell lung cancer

Rosell, R., Cecere, F., Cognetti, F., Cuello, M., Sanchez, J. M., Taron, M., Reguart, N. & Jablons, D., Feb 2006, In : Seminars in Oncology. 33, SUPPL. 1

Research output: Contribution to journalArticle

Gemcitabine at fixed dose-rate in patients with advanced soft tissue sarcomas: A mono-institutional phase II study

Ferraresi, V., Ciccarese, M., Cercato, M. C., Nuzzo, C., Zeuli, M., Di Filippo, F., Giannarelli, D. & Cognetti, F., Dec 2008, In : Cancer Chemotherapy and Pharmacology. 63, 1, p. 149-155 7 p.

Research output: Contribution to journalArticle

Gemcitabine-based combinations for inoperable pancreatic cancer: Have we made real progress? A meta-analysis of 20 phase 3 trials

Bria, E., Milella, M., Gelibter, A., Cuppone, F., Pino, M. S., Ruggeri, E. M., Carlini, P., Nisticò, C., Terzoli, E., Cognetti, F. & Giannarelli, D., Aug 1 2007, In : Cancer. 110, 3, p. 525-533 9 p.

Research output: Contribution to journalArticle

Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC)

Garufi, C., Giacomini, E., Torsello, A., Sperduti, I., Melucci, E., Mottolese, M., Zeuli, M., Ettorre, G. M., Ricciardi, T., Cognetti, F., Magnani, M. & Ruzzo, A., Sep 26 2016, In : Scientific Reports. 6, 34006.

Research output: Contribution to journalArticle

Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations

Ciuffreda, L., Del Bufalo, D., Desideri, M., Di Sanza, C., Stoppacciaro, A., Ricciardi, M. R., Chiaretti, S., Tavolaro, S., Benassi, B., Bellacosa, A., Foá, R., Tafuri, A., Cognetti, F., Anichini, A., Zupi, G. & Milella, M., Aug 2009, In : Neoplasia (United States). 11, 8, p. 720-731 12 p.

Research output: Contribution to journalArticle

HER2/neu expression and hormonal therapy in early breast cancer: Can muddy waters become clear?

Ferretti, G., Di Cosimo, S., Giannarelli, D., Carlini, P., Papaldo, P., Alimonti, A., Fabi, A., Mandalà, M., Milella, M., Ruggeri, E. M. & Cognetti, F., Feb 1 2004, In : Journal of Clinical Oncology. 22, 3, p. 568-569 2 p.

Research output: Contribution to journalArticle

HER2/neu role in breast cancer: From a prognostic foe to a predictive friend

Ferretti, G., Felici, A., Papaldo, P., Fabi, A. & Cognetti, F., Feb 2007, In : Current Opinion in Obstetrics and Gynecology. 19, 1, p. 56-62 7 p.

Research output: Contribution to journalArticle

HER2 and response to paclitaxel in node-positive breast cancer [10]

Ferretti, G., Felici, A. & Cognetti, F., Jan 10 2008, In : New England Journal of Medicine. 358, 2, p. 197 1 p.

Research output: Contribution to journalArticle

HER2 protein and gene variation between primary and metastatic breast cancer: Significance and impact on patient care

Fabi, A., Di Benedetto, A., Metro, G., Perracchio, L., Nisticò, C., Di Filippo, F., Ercolani, C., Ferretti, G., Melucci, E., Buglioni, S., Sperduti, I., Papaldo, P., Cognetti, F. & Mottolese, M., Apr 1 2011, In : Clinical Cancer Research. 17, 7, p. 2055-2064 10 p.

Research output: Contribution to journalArticle

High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide

Petronelli, A., Saulle, E., Pasquini, L., Petrucci, E., Mariani, G., Biffoni, M., Ferretti, G., Scambia, G., Benedetti-Panici, P., Greggi, S., Cognetti, F., Russo, M. A., Sporn, M. & Testa, U., Sep 18 2009, In : Cancer Letters. 282, 2, p. 214-228 15 p.

Research output: Contribution to journalArticle

Human malignant mesothelioma: Molecular mechanisms of pathogenesis and progression

Spugnini, E. P., Bosari, S., Citro, G., Lorenzon, I., Cognetti, F. & Baldi, A., 2006, In : International Journal of Biochemistry and Cell Biology. 38, 12, p. 2000-2004 5 p.

Research output: Contribution to journalArticle

Hypomagnesemia and cisplatinum: An evaluation of 54 patients

Cognetti, F., Pinnaro, P. & Cortese, M., 1982, In : Journal of Experimental and Clinical Cancer Research. 2, 1, p. 139-142 4 p.

Research output: Contribution to journalArticle

Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients

Venturini, M., Michelotti, A., Papaldo, P., Del Mastro, L., Bergaglio, M., Lionetto, R., Lunardi, G., Sguotti, C., Frevola, L., Donati, S., Rosso, R. & Cognetti, F., 2001, In : Annals of Oncology. 12, 8, p. 1097-1106 10 p.

Research output: Contribution to journalArticle

Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non small-cell lung cancer: A phase II study

Scinto, A. F., Ferraresi, V., Milella, M., Tucci, E., Santomaggio, C., Pasquali-Lasagni, R., Del Vecchio, M. R., Campioni, N., Nardi, M. & Cognetti, F., 1999, In : British Journal of Cancer. 81, 6, p. 1031-1036 6 p.

Research output: Contribution to journalArticle

Ifosfamide and epirubicin combination in untreated sarcomas: Two treatment schedules

Serrone, L., Zeuli, M., Papaldo, P., Nardoni, C., Pacetti, U. & Cognetti, F., 2001, In : Onkologie. 24, 5, p. 465-468 4 p.

Research output: Contribution to journalArticle

Ifosfamide and vinorelbine in advanced pretreated ovarian cancer: A phase II study

Nardi, M., De Marco, S., Fabi, A., Aloe, A., Magnani, E., Grandinetti, P. & Cognetti, F., 2000, In : Cancer Chemotherapy and Pharmacology. 45, 6, p. 513-515 3 p.

Research output: Contribution to journalArticle

Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial

Campisi, C., Fabi, A., Papaldo, P., Tomao, S., Massidda, B., Zappala, A., Ionta, M. T. & Cognetti, F., May 1998, In : Annals of Oncology. 9, 5, p. 565-567 3 p.

Research output: Contribution to journalArticle

Immunologic monitoring of surgically treated patients with ovarian cancer

Cordiali Fei, P., Mottolese, M. & Cognetti, F., 1978, IRCS Medical Science: Cancer. 9 ed. Vol. 6. p. 379 1 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: Results of a phase II study with biomarker evaluation

Fabi, A., Metro, G., Papaldo, P., Mottolese, M., Melucci, E., Carlini, P., Sperduti, I., Russillo, M., Gelibter, A., Ferretti, G., Tomao, S., Milella, M. & Cognetti, F., Sep 2008, In : Cancer Chemotherapy and Pharmacology. 62, 4, p. 717-725 9 p.

Research output: Contribution to journalArticle

Impact of gefitinib ('Iressa') treatment on the quality of life of patients with advanced non-small-cell lung cancer

Gelibter, A., Ceribelli, A., Pollera, C. F., Milella, M., Moscetti, L., Sperduti, I. & Cognetti, F., Dec 2005, In : Journal of Cancer Research and Clinical Oncology. 131, 12, p. 783-788 6 p.

Research output: Contribution to journalArticle

Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials

Cuppone, F., Bria, E., Giannarelli, D., Vaccaro, V., Milella, M., Nisticò, C., Ruggeri, E. M., Sperduti, I., Bracarda, S., Pinnarò, P., Lanzetta, G., Muti, P., Cognetti, F. & Carlini, P., Dec 9 2010, In : BMC Cancer. 10, 675.

Research output: Contribution to journalArticle

Impressive long-term response with pertuzumab and trastuzumab in HER2-positive breast cancer with brain metastasis

Russillo, M., Ferretti, G., Vidiri, A., Gasparro, S., Cognetti, F., Pellegrini, D. & Fabi, A., Jul 1 2018, In : In Vivo. 32, 4, p. 839-842 4 p.

Research output: Contribution to journalArticle

Improved control of cisplatin-induced emesis with a metoclopramide-dexamethasone combination

Cognetti, F., Pinnaro, P., Carlini, P., Caporali, C., Ruggeri, E. M. & Pollera, C. F., Oct 1984, In : Cancer Chemotherapy and Pharmacology. 13, 3, p. 235-237 3 p.

Research output: Contribution to journalArticle

Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer

Di Cosimo, S., Alimonti, A., Ferretti, G., Sperduti, I., Carlini, P., Papaldo, P., Fabi, A., Gelibter, A., Ciccarese, M., Giannarelli, D., Mandalà, M., Milella, M., Ruggeri, E. M. & Cognetti, F., Jul 2004, In : Annals of Oncology. 15, 7, p. 1065-1071 7 p.

Research output: Contribution to journalArticle

Induction chemotherapy (CT) with cisplatin, methotrexate, bleomycin and vincristine (CABO), before definitive treatment in patients with advanced squamous cell carcinoma of head and neck

Cognetti, F., Pinnaro, P. & Carlini, P., 1985, Proceedings of the American Association for Cancer Research. Vol. VOL. 26.

Research output: Chapter in Book/Report/Conference proceedingChapter

In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy

Metro, G., Zheng, Z., Fabi, A., Schell, M., Antoniani, B., Mottolese, M., Monteiro, A. N., Vici, P., Rivera, S. L., Boulware, D., Cognetti, F. & Bepler, G., 2010, In : Cancer Investigation. 28, 2, p. 172-180 9 p.

Research output: Contribution to journalArticle

Interleukin-2, interferon-α and interleukin-2 plus interferon-α in renal cell carcinoma. A randomized phase II trial

Boccardo, F., Rubagotti, A., Canobbio, L., Galligioni, E., Sorio, R., Lucenti, A., Cognetti, F., Ruggeri, E., Landonio, G., Baiocchi, C., Besana, C., Citterio, G., De Rosa, M. & Calabresi, F., 1998, In : Tumori. 84, 5, p. 534-539 6 p.

Research output: Contribution to journalArticle

Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: A phase II study

Nardi, M., Cognetti, F., Pollera, C. F., Della Giulia, M., Lombardi, A., Atlante, G. & Calabresi, F., 1990, In : Journal of Clinical Oncology. 8, 6, p. 1036-1041 6 p.

Research output: Contribution to journalArticle

Is anthracycline-based chemotherapy alone adequate for young women with estrogen receptor-positive breast cancer?

Papaldo, P., Di Cosimo, S., Ferretti, G., Carlini, P., Fabi, A., Cecere, F. & Cognetti, F., Apr 2006, In : Breast. 15, 2, p. 269-272 4 p.

Research output: Contribution to journalArticle

Is cardiac troponin T serum level an accurate surrogate for acute doxorubicin-related myocardial injury? [5]

Ferretti, G., Mandalà, M., Bria, E., Papaldo, P., Carlini, P., Fabi, A., Milella, M., Ruggeri, E. M., Nisticò, C. & Cognetti, F., Aug 2005, In : Annals of Oncology. 16, 8, p. 1403-1404 2 p.

Research output: Contribution to journalArticle

Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational study

Fabi, A., Barduagni, M., Lauro, S., Portalone, L., Mauri, M., Marinis, F., Narduzzi, C., Tonini, G., Giampaolo, M., Pacetti, U., Paoloni, F. & Cognetti, F., Mar 2003, In : Supportive Care in Cancer. 11, 3, p. 156-161 6 p.

Research output: Contribution to journalArticle

Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?

Ferretti, G., Bria, E., Giannarelli, D., Carlini, P., Felici, A., Mandalà, M., Papaldo, P., Fabi, A., Ciccarese, M., Cuppone, F., Cecere, F. L., Nuzzo, C., Terzoli, E. & Cognetti, F., Dec 2006, In : Chest. 130, 6, p. 1808-1816 9 p.

Research output: Contribution to journalArticle

Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening? [8]

Ferretti, G., Bria, E., Carlini, P., Felici, A., Giannarelli, D., Cuppone, F., Papaldo, P., Nisticò, C., Fabi, A., Gelibter, A., Terzoli, E. & Cognetti, F., Jun 2005, In : Gut. 54, 6, p. 891 1 p.

Research output: Contribution to journalArticle

Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women?

Carlini, P., Ferretti, G., Di Cosimo, S., Colella, E., Tonachella, R., Romiti, A., Tomao, S., Frassoldati, A., Papaldo, P., Fabi, A., Ruggeri, E. M. & Cognetti, F., Jul 2003, In : Journal of Steroid Biochemistry and Molecular Biology. 86, 1, p. 107-109 3 p.

Research output: Contribution to journalArticle

Is there a right-sided shift for colorectal cancer in women compared with men? [2]

Ferretti, G., Felici, A., Cognetti, F. & Mandala, M., May 2006, In : Cancer Epidemiology Biomarkers and Prevention. 15, 5, p. 1054-1055 2 p.

Research output: Contribution to journalArticle

Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., Marinis, F. D. E., Sperandi, F., Piantedosi, F., Vitali, M., Soto Parra, H. J., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., Jan 1 2019, In : Anticancer Research. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., DE Marinis, F., Sperandi, F., Piantedosi, F., Vitali, M., Parra, H. J. S., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., Aug 2019, In : Anticancer Research. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., Marinis, F. D. E., Sperandi, F., Piantedosi, F., Vitali, M., Soto Parra, H. J., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., 2019, In : Anticancer Research. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases: Anticancer Research

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., Marinis, F. D. E., Sperandi, F., Piantedosi, F., Vitali, M., Soto Parra, H. J., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., 2019, In : Anticancer Res.. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., DE Marinis, F., Sperandi, F., Piantedosi, F., Vitali, M., Parra, H. J. S., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., 2019, In : Anticancer Research. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients

Garassino, M. C., Gelibter, A. J., Grossi, F., Chiari, R., Soto Parra, H., Cascinu, S., Cognetti, F., Turci, D., Blasi, L., Bengala, C., Mini, E., Baldini, E., Quadrini, S., Ceresoli, G. L., Antonelli, P., Vasile, E., Pinto, C., Fasola, G., Galetta, D., Macerelli, M. & 3 others, Giannarelli, D., Lo Russo, G. & de Marinis, F., Aug 1 2018, In : Journal of Thoracic Oncology. 13, 8, p. 1146-1155 10 p.

Research output: Contribution to journalArticle